How important is hyperglycemia during acute brain infarction?

Askiel Bruno, Linda S. Williams, Thomas A. Kent

Research output: Contribution to journalReview article

39 Citations (Scopus)

Abstract

Background: Although well supported by animal studies, it remains unproven whether lowering hyperglycemia during acute cerebral infarction will improve outcomes. Further support for this therapeutic approach comes from clinical studies in acute myocardial infarction and in ventilated postsurgical patients, where lowering hyperglycemia improved outcomes. Review Summary: Animal studies support the hypothesis that hyperglycemia during acute brain ischemia augments the brain injury, but only in models with reperfusion. The available human studies to date are all observational and they usually find an association between hyperglycemia during acute cerebral infarction and worse outcome. Also, there is evidence that hyperglycemia during acute cerebral infarction is detrimental only with reperfusion. This association appears to be linear in the glucose ranges tested (normal to high). In addition, there is an association between admission hyperglycemia and hemorrhagic conversion of an acute cerebral infarct when thrombolytics are used. Conclusion: Sufficient evidence has accumulated to proceed to clinical efficacy trials to see if tight glycemic control compared with persistent hyperglycemia during acute cerebral infarction will improve outcomes. If such therapy proves beneficial, the increased cost, effort, and risk associated with tight glycemic control during acute cerebral infarction could be justified. Randomized clinical trials to test this hypothesis are currently in progress.

Original languageEnglish (US)
Pages (from-to)195-200
Number of pages6
JournalNeurologist
Volume10
Issue number4
DOIs
StatePublished - Jul 1 2004

Fingerprint

Brain Infarction
Hyperglycemia
Cerebral Infarction
Reperfusion
Brain Ischemia
Brain Injuries
Reference Values
Randomized Controlled Trials
Myocardial Infarction
Clinical Trials
Costs and Cost Analysis
Glucose
Therapeutics

Keywords

  • Cerebral infarction
  • Cerebral perfusion
  • Hyperglycemia

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

How important is hyperglycemia during acute brain infarction? / Bruno, Askiel; Williams, Linda S.; Kent, Thomas A.

In: Neurologist, Vol. 10, No. 4, 01.07.2004, p. 195-200.

Research output: Contribution to journalReview article

Bruno, Askiel ; Williams, Linda S. ; Kent, Thomas A. / How important is hyperglycemia during acute brain infarction?. In: Neurologist. 2004 ; Vol. 10, No. 4. pp. 195-200.
@article{9e65d3c337cd402bba11ba185ed4e316,
title = "How important is hyperglycemia during acute brain infarction?",
abstract = "Background: Although well supported by animal studies, it remains unproven whether lowering hyperglycemia during acute cerebral infarction will improve outcomes. Further support for this therapeutic approach comes from clinical studies in acute myocardial infarction and in ventilated postsurgical patients, where lowering hyperglycemia improved outcomes. Review Summary: Animal studies support the hypothesis that hyperglycemia during acute brain ischemia augments the brain injury, but only in models with reperfusion. The available human studies to date are all observational and they usually find an association between hyperglycemia during acute cerebral infarction and worse outcome. Also, there is evidence that hyperglycemia during acute cerebral infarction is detrimental only with reperfusion. This association appears to be linear in the glucose ranges tested (normal to high). In addition, there is an association between admission hyperglycemia and hemorrhagic conversion of an acute cerebral infarct when thrombolytics are used. Conclusion: Sufficient evidence has accumulated to proceed to clinical efficacy trials to see if tight glycemic control compared with persistent hyperglycemia during acute cerebral infarction will improve outcomes. If such therapy proves beneficial, the increased cost, effort, and risk associated with tight glycemic control during acute cerebral infarction could be justified. Randomized clinical trials to test this hypothesis are currently in progress.",
keywords = "Cerebral infarction, Cerebral perfusion, Hyperglycemia",
author = "Askiel Bruno and Williams, {Linda S.} and Kent, {Thomas A.}",
year = "2004",
month = "7",
day = "1",
doi = "10.1097/01.nrl.0000131800.77824.dd",
language = "English (US)",
volume = "10",
pages = "195--200",
journal = "Neurologist",
issn = "1074-7931",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - How important is hyperglycemia during acute brain infarction?

AU - Bruno, Askiel

AU - Williams, Linda S.

AU - Kent, Thomas A.

PY - 2004/7/1

Y1 - 2004/7/1

N2 - Background: Although well supported by animal studies, it remains unproven whether lowering hyperglycemia during acute cerebral infarction will improve outcomes. Further support for this therapeutic approach comes from clinical studies in acute myocardial infarction and in ventilated postsurgical patients, where lowering hyperglycemia improved outcomes. Review Summary: Animal studies support the hypothesis that hyperglycemia during acute brain ischemia augments the brain injury, but only in models with reperfusion. The available human studies to date are all observational and they usually find an association between hyperglycemia during acute cerebral infarction and worse outcome. Also, there is evidence that hyperglycemia during acute cerebral infarction is detrimental only with reperfusion. This association appears to be linear in the glucose ranges tested (normal to high). In addition, there is an association between admission hyperglycemia and hemorrhagic conversion of an acute cerebral infarct when thrombolytics are used. Conclusion: Sufficient evidence has accumulated to proceed to clinical efficacy trials to see if tight glycemic control compared with persistent hyperglycemia during acute cerebral infarction will improve outcomes. If such therapy proves beneficial, the increased cost, effort, and risk associated with tight glycemic control during acute cerebral infarction could be justified. Randomized clinical trials to test this hypothesis are currently in progress.

AB - Background: Although well supported by animal studies, it remains unproven whether lowering hyperglycemia during acute cerebral infarction will improve outcomes. Further support for this therapeutic approach comes from clinical studies in acute myocardial infarction and in ventilated postsurgical patients, where lowering hyperglycemia improved outcomes. Review Summary: Animal studies support the hypothesis that hyperglycemia during acute brain ischemia augments the brain injury, but only in models with reperfusion. The available human studies to date are all observational and they usually find an association between hyperglycemia during acute cerebral infarction and worse outcome. Also, there is evidence that hyperglycemia during acute cerebral infarction is detrimental only with reperfusion. This association appears to be linear in the glucose ranges tested (normal to high). In addition, there is an association between admission hyperglycemia and hemorrhagic conversion of an acute cerebral infarct when thrombolytics are used. Conclusion: Sufficient evidence has accumulated to proceed to clinical efficacy trials to see if tight glycemic control compared with persistent hyperglycemia during acute cerebral infarction will improve outcomes. If such therapy proves beneficial, the increased cost, effort, and risk associated with tight glycemic control during acute cerebral infarction could be justified. Randomized clinical trials to test this hypothesis are currently in progress.

KW - Cerebral infarction

KW - Cerebral perfusion

KW - Hyperglycemia

UR - http://www.scopus.com/inward/record.url?scp=3242657072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242657072&partnerID=8YFLogxK

U2 - 10.1097/01.nrl.0000131800.77824.dd

DO - 10.1097/01.nrl.0000131800.77824.dd

M3 - Review article

VL - 10

SP - 195

EP - 200

JO - Neurologist

JF - Neurologist

SN - 1074-7931

IS - 4

ER -